Mayo Clinic Develops Potential New Therapy To Stop The Progression Of Parkinson’s Disease

Mayo Clinic (http://www.mayoclinic.org) researchers have developed a method to reduce the production of alpha-synuclein in the brain. Alpha-synuclein is a protein that is believed to be central to the cause of Parkinson’s disease (http://www.mayoclinic.org/parkinsons- disease).

More: continued here

Filed under: Parkinson's Disease on November 21st, 2008